Home / Ifosfamide / Germany
DE ATC L01AA06 · updated 2 Nov 2026
Ifosfamide shortage in Germany
Is there an Ifosfamide shortage in Germany?
Yes. As of 2 Nov 2026, 10 Ifosfamide products are reported short in Germany, the first since 21 Jan 2026. The company estimate for the return is 31 Dec 2026 (latest 31 Dec 2027). Main reason: manufacturing problem.
Also short in United States, France, Italy, Austria, Belgium, Switzerland, Czechia, Norway, Sweden, Japan, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Holoxan | Baxter Deutschland GmbH | 21 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Holoxan | Baxter Deutschland GmbH | 21 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Holoxan | Baxter Deutschland GmbH | 21 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Holoxan | Baxter Deutschland GmbH | 21 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Holoxan | Baxter Deutschland GmbH | 21 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Holoxan | Baxter Deutschland GmbH | 21 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | IFO-cell 2g Konzentrat zur Herstellung einer Infusionslösung | STADAPHARM GmbH | 3 Aug 2026 | 31 Dec 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | IFO-cell 5 g Konzentrat zur Herstellung einer Infusionslösung | STADAPHARM GmbH | 17 Aug 2026 | 31 Dec 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | IFO-cell N 1000 | STADAPHARM GmbH | 17 Aug 2026 | 31 Dec 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | IFO-cell N 2000 | STADAPHARM GmbH | 17 Aug 2026 | 31 Dec 2027 | Manufacturing problem Probleme in der Herstellung |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.